Brain natriuretic peptide and C-type natriuretic peptide are differently regulated by age but similarly elevated in coronary artery disease

Acta Cardiologica

Volumn 61, Issue 1, 2006, Pages 1-5

  Hong, Ta Chun ^a   Yeh, Hung I ^a   Shih, Bing Fu ^a   Wang, An Mei ^a   Chen, Chun Yen ^a   Hou, Charles Jia Yin ^a   Tsai, Cheng Ho ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Age; Angioplasty; BNP; CNP; Coronary artery disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C;

ACUTE DISEASE; ADULT; AGE; AGED; AGING; ARTICLE; BLOOD VESSEL INJURY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGE FACTORS; AGED; ANGIOPLASTY; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; STATISTICS, NONPARAMETRIC;

EID: 32044432876     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.1.2005133     Document Type: Article

References (26)

1. Jortani SA, Prabhu SD, Valdes R, Jr. Strategies for developing biomarkers of heart failure. Clin Chem 2004; 50: 265-78.
2. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24: 341-56.
3. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992; 262: H308-H312.
4. Han B, Hasin Y. Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1. Cardiovasc Drugs Ther 2003; 17: 41-52.
5. Beltowski J, Wojcicka G. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002; 8: RA39-RA52.
6. Ohata T, Sakakibara T, Takano H, Izutani H. Plasma brain natriuretic peptide reflects left ventricular function during percutaneous cardiopulmonary support. Ann Thorac Surg 2004; 77: 164-7.
7. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105-7.
8. Kalra PR, Clague JR, Bolger AP, Anker SD, Poole-Wilson PA, Struthers AD, Coats AJ. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 2003; 107: 571-3.
9. Freitag MH, Vasan RS. Screening for left ventricular systolic dysfunction: the use of B-type natriuretic peptide. Heart Fail Monit 2003; 4: 38-44.
10. Asada J, Tsuji H, Iwasaka T, Thomas JD, Lauer MS. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 2004; 93: 702-4.
11. Katayama T, Nakashima H, Yonekura T, Honda Y, Suzuki S, Yano K. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. J Cardiol 2003; 42: 195-200.
12. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-7.
13. ten Wolde M, Tulevski II, Mulder JW, Sohne M, Boomsma F, Mulder BJ, Buller HR. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082-4.
14. Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, Kihara Y, Nohara R, Sasayama S. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 399-403.
15. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 1994; 78: 1428-35.
16. Jaarsma T, Stewart S, De Geest S, Fridlund B, Heikkila J, Martensson J, Moons P, Op Reimer WS, Smith K, Stromberg A, Thompson DR. A survey of coronary risk factors and B-type natriuretic peptide concentrations in cardiac nurses from Europe: do nurses still practice what they preach? Eur J Cardiovasc Nurs 2004; 3: 3-6.
17. Kawai K, Hata K, Tanaka K, Kubota Y, Inoue R, Masuda E, Miyazaki T, Yokoyama M. Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging. Am J Cardiol 2004; 93: 719-23.
18. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; Breathing Not Properly Multinational Study Investigators. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003; 41: 571-9.
19. Nomura H, Hayashi T, Esaki T, Kanda S, Kano H, Hattori A, Iguchi A. Standardization of plasma brain natriuretic peptide concentrations in older Japanese-relationship to latent renal dysfunction and ischemic heart disease. J Am Geriatr Soc 2002; 50: 1504-1509.
20. Nappi JM. The role of B-type natriuretic peptide in heart failure. Crit Care Nurs Clin North Am 2003; 15: 461-5.
21. Marie PY, Mertes PM, Hassan-Sebbag N, de Talence N, Djaballah K, Djaballah W, Friberg J, Olivier P, Karcher G, Zannad F, Bertrand A. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Am Coll Cardiol 2004; 43: 353-9.
22. Kyriakides ZS, Markianos M, Michalis L, Antoniadis A, Nikolaou NI, Kremastinos DT. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 2000; 23: 285-8.
23. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000; 23: 776-80.
24. Cargill RI, Barr CS, Coutie WJ, Struthers AD, Lipworth BJ. C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure. Thorax 1994; 49: 1247-9.
25. Cheung BM, Brown MJ. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertens 1994; 12: 449-54.
26. Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, Tanaka I, Mori K, Nakao K. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994; 198: 1177-82.